Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans

Annals of the New York Academy of Sciences

Volumn 1100, Issue , 2007, Pages 530-542

  Gruber, Jan ^a   Soon, Yew Tang ^a   Halliwell, Barry ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Aging; Caenorhabditis elegans; Fitness; Resveratrol; Stress; Trade off

Indexed keywords

RESVERATROL; ANTIOXIDANT; CAENORHABDITIS ELEGANS PROTEIN; FLAVONOID; HELMINTH PROTEIN; PARAQUAT; PHENOL DERIVATIVE; POLYPHENOLS; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CAENORHABDITIS ELEGANS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; LIFESPAN; METABOLISM; MORTALITY; NONHUMAN; OXIDATIVE STRESS; SUBFERTILITY; SURVIVAL; ANIMAL; ARTICLE; CELL AGING; CELL SURVIVAL; CHEMICAL MODEL; CHEMISTRY; PHYSIOLOGY; TIME; WINE;

CAENORHABDITIS ELEGANS; NEMATODA;

ANIMALS; ANTIOXIDANTS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CELL AGING; CELL SURVIVAL; FLAVONOIDS; HELMINTH PROTEINS; METABOLIC NETWORKS AND PATHWAYS; MODELS, CHEMICAL; OXIDATIVE STRESS; PARAQUAT; PHENOLS; STILBENES; TIME FACTORS; WINE;

EID: 34249750383     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1395.059     Document Type: Conference Paper

References (27)

1. LAMMING, D.W., J.G. WOOD & D.A. SINCLAIR. 2004. Small molecules that regulate lifespan: evidence for xenohormesis. Mol. Microbiol. 53: 1003-1009.
2. BAUR, J.A. & D.A. SINCLAIR. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5: 493-506.
3. CELOTTI, E., R. FERRARINI, R. ZIRONI & L.S. CONTE. 1996. Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J. Chromatogr. A 730: 47-52.
4. RENAUD, S. & L.M. DE. 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526.
5. BANERJEE, S., C. BUESO-RAMOS & B.B. AGGARWAL. 2002. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62: 4945-4954.
6. JANG, M., L. CAI, G.O. UDEANI, et al. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
7. LI, Z.G., T. HONG, Y. SHIMADA, et al. 2002. Suppression of N-nitrosomethyl-benzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 23: 1531-1536.
8. TESSITORE, L., A. DAVIT, I. SAROTTO & G. CADERNI. 2000. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21: 1619-1622.
9. AUGER, C., P.L. TEISSEDRE, P. GERAIN, et al. 2005. Dietary wine phenolics catechin, quercetin, and resveratrol efficiently protect hypercholesterolemic hamsters against aortic fatty streak accumulation. J. Agric. Food Chem. 53: 2015-2021.
10. BRADAMANTE, S., L. BARENGHI & A. VILLA. 2004. Cardiovascular protective effects of resveratrol. Cardiovasc. Drug Rev. 22: 169-188.
11. WANG, Z., J. ZOU, K. CAO, et al. 2005. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int. J. Mol. Med. 16: 533-540.
12. SINHA, K., G. CHAUDHARY & Y.K. GUPTA. 2002. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci. 71: 655-665.
13. WANG, Q., J. XU, G.E. ROTTINGHAUS, et al. 2002. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958: 439-447.
14. BERTELLI, A.A., L. GIOVANNINI, D. GIANNESSI, et al. 1995. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int. J. Tissue React. 17: 1-3.
15. WANG, Z., J. ZOU, Y. HUANG, et al. 2002. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chin. Med. J. (Engl) 115: 378-380.
16. HOWITZ, K.T., K.J. BITTERMAN, H.Y. COHEN, et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196.
17. VALENZANO, D.R., E. TERZIBASI, T. GENADE, et al. 2006. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 16: 296-300.
18. WOOD, J.G., B. ROGINA, S. LAVU, et al. 2004. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430: 686-689.
19. GOLDBERG, D.M., J. YAN & G.J. SOLEAS. 2003. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36: 79-87.
20. WALLE, T., F. HSIEH, M.H. DELEGGE, et al. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug. Metab. Dispos. 32: 1377-1382.
21. GEMS, D., A.J. SUTTON, M.L. SUNDERMEYER, et al. 1998. Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics 150: 129-155.
22. KENYON, C., J. CHANG, E. GENSCH, et al. 1993. A C. elegans mutant that lives twice as long as wild type. Nature 366: 461-464.
23. LARSEN, P.L., P.S. ALBERT & D.L. RIDDLE. 1995. Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics 139: 1567-1583.
24. HOSONO, R., Y. MITSUI, Y. SATO, et al. 1982. Life span of the wild and mutant nematode Caenorhabditis elegans. Effects of sex, sterilization, and temperature. Exp. Gerontol. 17: 163-172.
25. HUANG, C., C. XIONG & K. KORNFELD. 2004. Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans. Proc. Nat. Acad. Sci. USA 101: 8084-8089.
26. WALKER, D.W., G. MCCOLL, N.L. JENKINS, et al. 2000. Evolution of lifespan in C. elegans. Nature 405: 296-297.
27. WILSON, M.A., B. SHUKITT-HALE, W. KALT, et al. 2006. Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans. Aging Cell 5: 59-68.